FDA.reportPublic FDA data

chlorhexidine gluconate 20 MG/ML / ketoconazole 10 MG/ML Topical Spray [Keto-C]

RxCUI
1797515
RxNorm name
chlorhexidine gluconate 20 MG/ML / ketoconazole 10 MG/ML Topical Spray [Keto-C]
Term type
SBD
Status
Active
Updated
2026-11-11 03:17:10

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
072016
Active start
072016
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
chlorhexidine gluconate20 MG / 1 MLchlorhexidinechlorhexidine gluconate
ketoconazole10 MG / 1 MLketoconazoleketoconazole

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Spray346165

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
chlorhexidine2358
ketoconazole6135

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRKeto-C 2 % / 1 % Topical Spray1NAMES
RxNorm Namechlorhexidine gluconate 20 MG/ML / ketoconazole 10 MG/ML Topical Spray [Keto-C]1NAMES
RxNorm SynonymKeto-C 2 % / 1 % Topical Spray1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID
2 linked values
2CODES
RxCUI17975151CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 3 matching rows.

NDC11, Source, Active table
NDC11SourceActive
86069010304rxnav_ndcsyes
86069010308rxnav_ndcsyes
86069013803rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d934aa76-4535-4b6a-ab4b-5b02aa9890f7Keto-C 2 % / 1 % Topical Spray [PSN] · chlorhexidine gluconate 20 MG/ML / ketoconazole 10 MG/ML Topical Spray [Keto-C] [SBD] · Keto-C 2 % / 1 % Topical Spray [SY]310Keto-C ® Spray20221109
b4020044-fe68-4c18-99f2-20df7e6e8496Keto-C 2 % / 1 % Topical Spray [PSN] · chlorhexidine gluconate 20 MG/ML / ketoconazole 10 MG/ML Topical Spray [Keto-C] [SBD] · Keto-C 2 % / 1 % Topical Spray [SY]31STRATFORD Keto-C ​® ​ SPRAY WITH CeraGuard ​TM ​20260204

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
b4020044-fe68-4c18-99f2-20df7e6e8496STRATFORD Keto-C ​® ​ SPRAY WITH CeraGuard ​TM ​Stratford Care Usa, Inc.20260204
d934aa76-4535-4b6a-ab4b-5b02aa9890f7Keto-C ® SprayStratford Care Usa, Inc.20221109

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCH02CAAnticorticosteroidsATC1-4ketoconazole
ATCS02AAAntiinfectivesATC1-4chlorhexidine
ATCS03AAAntiinfectivesATC1-4chlorhexidine
ATCB05CAAntiinfectivesATC1-4chlorhexidine
ATCA01ABAntiinfectives and antiseptics for local oral treatmentATC1-4chlorhexidine
ATCR02AAAntisepticsATC1-4chlorhexidine
ATCD08ACBiguanides and amidinesATC1-4chlorhexidine
ATCD01ACImidazole and triazole derivativesATC1-4ketoconazole
ATCG01AFImidazole derivativesATC1-4ketoconazole
ATCJ02ABImidazole derivativesATC1-4ketoconazole
ATCD09AAMedicated dressings with antiinfectivesATC1-4chlorhexidine
ATCS01AXOther antiinfectivesATC1-4chlorhexidine
FDASPLD001393AzolesCHEMhas_chemical_structureketoconazole
FDASPLN0000175487Azole AntifungalEPChas_epcketoconazole
FDASPLN0000182141Cytochrome P450 3A4 InhibitorsMOAhas_moaketoconazole
FDASPLN0000190115Cytochrome P450 3A5 InhibitorsMOAhas_moaketoconazole
FDASPLN0000185503P-Glycoprotein InhibitorsMOAhas_moaketoconazole
FDASPLN0000008478Decreased Cell Wall IntegrityPEhas_pechlorhexidine
MEDRTD000525AlprazolamCHEMci_chemclassketoconazole
MEDRTD016589AstemizoleCHEMci_chemclassketoconazole
MEDRTD002710ChlorhexidineCHEMhas_ingredientchlorhexidine gluconate
MEDRTD002710ChlorhexidineCHEMhas_ingredientchlorhexidine
MEDRTD020117CisaprideCHEMci_chemclassketoconazole
MEDRTD003078ColchicineCHEMci_chemclassketoconazole
MEDRTD004087DihydroergotamineCHEMci_chemclassketoconazole
MEDRTD004206DisopyramideCHEMci_chemclassketoconazole
MEDRTD000077764DronedaroneCHEMci_chemclassketoconazole
MEDRTD000077545EplerenoneCHEMci_chemclassketoconazole
MEDRTD004874ErgonovineCHEMci_chemclassketoconazole
MEDRTD004878ErgotamineCHEMci_chemclassketoconazole
MEDRTD015736FelodipineCHEMci_chemclassketoconazole
MEDRTD000077146IrinotecanCHEMci_chemclassketoconazole
MEDRTD007654KetoconazoleCHEMhas_ingredientketoconazole
MEDRTD008148LovastatinCHEMci_chemclassketoconazole
MEDRTD000069056Lurasidone HydrochlorideCHEMci_chemclassketoconazole
MEDRTD008691MethadoneCHEMci_chemclassketoconazole
MEDRTD008755MethylergonovineCHEMci_chemclassketoconazole
MEDRTD008874MidazolamCHEMci_chemclassketoconazole
MEDRTD015737NisoldipineCHEMci_chemclassketoconazole
MEDRTD010627PhenethylaminesCHEMci_chemclassketoconazole
MEDRTD010868PimozideCHEMci_chemclassketoconazole
MEDRTD011802QuinidineCHEMci_chemclassketoconazole
MEDRTD000069458RanolazineCHEMci_chemclassketoconazole
MEDRTD019821SimvastatinCHEMci_chemclassketoconazole
MEDRTD013449SulfonamidesCHEMci_chemclassketoconazole
MEDRTD016593TerfenadineCHEMci_chemclassketoconazole
MEDRTD000077602TolvaptanCHEMci_chemclassketoconazole
MEDRTD014229TriazolamCHEMci_chemclassketoconazole
MEDRTD015823Acanthamoeba KeratitisDISEASEmay_treatketoconazole
MEDRTD017088AIDS-Related Opportunistic InfectionsDISEASEmay_preventketoconazole
MEDRTD001759BlastomycosisDISEASEmay_treatketoconazole
MEDRTD002178Candidiasis, Chronic MucocutaneousDISEASEmay_treatketoconazole
MEDRTD002179Candidiasis, CutaneousDISEASEmay_treatketoconazole
MEDRTD002180Candidiasis, OralDISEASEmay_treatchlorhexidine gluconate
MEDRTD002180Candidiasis, OralDISEASEmay_treatketoconazole
MEDRTD002180Candidiasis, OralDISEASEmay_treatchlorhexidine
MEDRTD002181Candidiasis, VulvovaginalDISEASEmay_treatketoconazole
MEDRTD020314Central Nervous System Fungal InfectionsDISEASEci_withketoconazole
MEDRTD003047CoccidioidomycosisDISEASEmay_treatketoconazole
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatketoconazole
MEDRTD004342Drug HypersensitivityDISEASEci_withchlorhexidine
MEDRTD004342Drug HypersensitivityDISEASEci_withchlorhexidine gluconate
MEDRTD016905Gram-Negative Bacterial InfectionsDISEASEmay_treatchlorhexidine gluconate
MEDRTD016905Gram-Negative Bacterial InfectionsDISEASEmay_treatchlorhexidine
MEDRTD016908Gram-Positive Bacterial InfectionsDISEASEmay_treatchlorhexidine
MEDRTD016908Gram-Positive Bacterial InfectionsDISEASEmay_treatchlorhexidine gluconate
MEDRTD006660HistoplasmosisDISEASEmay_treatketoconazole
MEDRTD007896LeishmaniasisDISEASEmay_treatketoconazole
MEDRTD008107Liver DiseasesDISEASEci_withketoconazole
MEDRTD010229ParacoccidioidomycosisDISEASEmay_treatketoconazole
MEDRTD010510Periodontal DiseasesDISEASEmay_treatchlorhexidine gluconate
MEDRTD010510Periodontal DiseasesDISEASEmay_treatchlorhexidine
MEDRTD012874Skin Diseases, InfectiousDISEASEmay_treatchlorhexidine gluconate
MEDRTD012874Skin Diseases, InfectiousDISEASEmay_treatchlorhexidine
MEDRTD014008Tinea PedisDISEASEmay_treatketoconazole
MEDRTD014010Tinea VersicolorDISEASEmay_treatketoconazole
MEDRTN000002002514-alpha Demethylase InhibitorsMOAhas_moaketoconazole
MEDRTN0000009957Ergosterol Synthesis InhibitorsMOAhas_moaketoconazole
MEDRTN0000000065Physiochemical ActivityMOAhas_moachlorhexidine gluconate
MEDRTN0000000065Physiochemical ActivityMOAhas_moachlorhexidine
MEDRTN0000008476Decreased Cell Membrane IntegrityPEhas_peketoconazole
MEDRTN0000008478Decreased Cell Wall IntegrityPEhas_pechlorhexidine
MEDRTN0000008478Decreased Cell Wall IntegrityPEhas_pechlorhexidine gluconate
MEDRTN0000008478Decreased Cell Wall IntegrityPEhas_peketoconazole

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_VET_DRUGUS
ATTRIBUTESVET_DRUGUS
NAMESPrescribable SynonymKeto-C 2 % / 1 % Topical Spray
SOURCESSourceMetathesaurus FDA Structured Product Labels